Dexcom is working to replace some of the receivers that link with its continuous glucose monitoring systems due to a defective speaker, after a number of the devices failed to provide audio alarms of ...
FDA classifies this as a Class I recall, which means using the device could result in adverse health effects or death. Dexcom Inc., has recalled its G4 Platinum and G5 Mobile continuous glucose ...
An urgent recall has gone out for a popular medical device used by millions of Americans with diabetes. The US Food and Drug Administration (FDA) has revealed that over two million blood glucose ...
Continuous glucose monitor company Dexcom has hit a stumbling block. Some of its devices, including the G5 receiver for a system that just launched last fall, are not providing the audio alarms and ...
Please provide your email address to receive an email when new articles are posted on . Dexcom Inc. issued a recall of its continuous glucose monitoring systems because the audible alarm may not ...
SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc., (NASDAQ:DXCM), a leader in continuous glucose monitoring (CGM) for patients with diabetes, announced today that it has received U.S. Food and Drug ...